ANIP

ANI Pharmaceuticals (ANIP) Investor Questions

Review ANI Pharmaceuticals (ANIP) faq with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Company
ANI Pharmaceuticals
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Overall BTI score
63
Annual revenue
$883.37M
Annual net income
$78.34M
Annual free cash flow
$150.90M

ANI Pharmaceuticals (ANIP) Investor Questions research

ANI Pharmaceuticals trades under the ticker ANIP. The company is classified in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry.

Investors commonly review ANIP through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.